$3.43
3.92% yesterday
Nasdaq, Aug 21, 10:00 pm CET
ISIN
KYG9442G1047
Symbol
UPC

Universe Pharmaceuticals INC Stock price

$3.43
-0.05 1.44% 1M
-4.63 57.42% 6M
-20.97 85.94% YTD
-1,904.57 99.82% 1Y
-2,156.21 99.84% 3Y
-17,096.57 99.98% 5Y
-17,096.57 99.98% 10Y
-17,096.57 99.98% 20Y
Nasdaq, Closing price Thu, Aug 21 2025
-0.14 3.92%
ISIN
KYG9442G1047
Symbol
UPC
Industry

Key metrics

Basic
Market capitalization
$2.0m
Enterprise Value
$-37.5m
Net debt
positive
Cash
$47.3m
Shares outstanding
560.0k
Valuation (TTM | estimate)
P/E
1.1 | -
P/S
0.1 | -
EV/Sales
negative | -
EV/FCF
3.1
P/B
0.0
Financial Health
Equity Ratio
67.0%
Return on Equity
-19.2%
ROCE
-15.0%
ROIC
-52.6%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$19.3m | -
EBITDA
$-8.1m | -
EBIT
$-8.6m | -
Net Income
$1.1m | -
Free Cash Flow
$-12.0m
Growth (TTM | estimate)
Revenue
-27.8% | -
EBITDA
-41.1% | -
EBIT
-46.9% | -
Net Income
105.7% | -
Free Cash Flow
-94.8%
Margin (TTM | estimate)
Gross
30.4%
EBITDA
-42.0% | -
EBIT
-44.6%
Net
5.7% | -
Free Cash Flow
-62.4%
More
EPS
$3.1
FCF per Share
$-21.5
Short interest
4.4%
Employees
225
Rev per Employee
$100.0k
Show more

Is Universe Pharmaceuticals INC a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,014 stocks worldwide.

Financial data from Universe Pharmaceuticals INC

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
19 19
28% 28%
100%
- Direct Costs 13 13
30% 30%
70%
5.87 5.87
22% 22%
30%
- Selling and Administrative Expenses 11 11
7% 7%
59%
- Research and Development Expense 3.01 3.01
13% 13%
16%
-8.10 -8.10
41% 41%
-42%
- Depreciation and Amortization 0.51 0.51
325% 325%
3%
EBIT (Operating Income) EBIT -8.61 -8.61
47% 47%
-45%
Net Profit 1.09 1.09
106% 106%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Universe Pharmaceuticals INC directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Universe Pharmaceuticals INC Stock News

Neutral
GlobeNewsWire
5 months ago
Jiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of 40 ordinary shares with par value of US$0.28125 per share each in the Company's issued and unissued share capital into one (1) ord...
Neutral
GlobeNewsWire
6 months ago
Ji'an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on February 19, 2025, the Company received a staff determination notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is delinquent in fi...

Company Profile

Universe Pharmaceuticals, Inc. manufactures, markets, and distributes traditional derivative products. It also sells biomedical drugs, medical instruments, traditional and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on December 12, 1998 and is headquartered in Ji'an, China.

Head office Cayman Islands
CEO Gang Lai
Employees 225
Founded 1998
Website www.universe-pharmacy.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today